In the present study,
1-(3-methoxy-phenyl)-3-naphthalen-1-yl-propenone
(MPNP) is synthesized and characterized by several experimental techniques
such as Fourier transform-infrared spectroscopy (FT-IR), FT-Raman,
NMR and UV–vis spectral methods. The similar techniques are
also investigated by the computational method using Gaussian software.
The density functional theory (DFT) method is used to obtain the optimized
structure using the B3LYP/6-311++G(d,p) basis set. This optimization
procedure of the molecule gives the minimum energy confirmation of
the structure. The computed geometrical parameters are compared with
experimental data. The experimental FT-IR and FT-Raman spectra of
MPNP are obtained in the regions 4000–400 and 4000–50
cm–1 respectively. The detailed vibrational assignments
of the molecule are obtained with the support of potential energy
distribution. The theoretical NMR (1H and 13C) analysis is conducted by the GIAO method for its structural characterization
and compared with experimental chemical shifts. The experimental UV–vis
spectrum is obtained in the dimethyl sulfoxide solvent and compared
with the theoretically computed spectrum by the time-dependent DFT
method. In addition to these studies, other analyses such as nonlinear
optical, natural bonds orbital, frontier molecular orbital, molecular
electrostatic potential, and NCI have been conducted to understand
the nature of the molecule. The title molecule is docked and also
the drug-likeness, ADMET studies were carried out. The RBD domain
bound to the ACE2 receptor during the fusion makes spike glycoprotein
an elusive therapeutic target in SARS-CoV-2 infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.